The PI3K/mTOR dual inhibitor GSK458 potently impedes ovarian cancer tumorigenesis and metastasis.
Saved in:
| Title: | The PI3K/mTOR dual inhibitor GSK458 potently impedes ovarian cancer tumorigenesis and metastasis. |
|---|---|
| Authors: | Xiao, Yangjiong1,2,3,4 (AUTHOR) xiaoyangjiong@alumni.sjtu.edu.cn, Yu, Yang4 (AUTHOR), Jiang, Pengcheng5 (AUTHOR), Li, Yuhong6 (AUTHOR), Wang, Chao6 (AUTHOR), Zhang, Rong1 (AUTHOR) rongzhang@163.com |
| Source: | Cellular Oncology (2211-3428). Aug2020, Vol. 43 Issue 4, p669-680. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 22113428 |
|---|---|
| DOI: | 10.1007/s13402-020-00514-8 |
